US 9,809,540 B2
Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N'-(3-fluoro-2-methylphenyl)urea
Francis Dominic Sanderson, Ware (GB); and Sarah Mary Vallance, Stevenage (GB)
Assigned to GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED, (GB)
Appl. No. 15/34,583
Filed by GlaxoSmithKline Intellectual Property (No.2) Limited, Brentford, Middlesex (GB)
PCT Filed Nov. 11, 2014, PCT No. PCT/EP2014/074222
§ 371(c)(1), (2) Date May 5, 2016,
PCT Pub. No. WO2015/071235, PCT Pub. Date May 21, 2015.
Claims priority of application No. 1320021.7 (GB), filed on Nov. 13, 2013.
Prior Publication US 2016/0264525 A1, Sep. 15, 2016
Int. Cl. C07D 211/54 (2006.01); A61K 31/4462 (2006.01)
CPC C07D 211/54 (2013.01) [A61K 31/4462 (2013.01)] 6 Claims
 
1. A compound which is a hemihydrate of the hydrobromide salt of N-{4-chloro-2-hydroxy-3-[(3S)-3-piperidinylsulfonyl]phenyl}-N′-(3-fluoro-2-methylphenyl)urea.